Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart

被引:73
作者
Kostic, MM
Erdogan, S
Rena, G
Borchert, G
Hoch, B
Bartel, S
Scotland, G
Huston, E
Houslay, MD
Krause, EG
机构
[1] MAX DELBRUCK CTR MOL MED, DEPT MOL CARDIOL, D-13125 BERLIN, GERMANY
[2] UNIV GLASGOW, IBLS, DIV BIOCHEM & MOL BIOL, MOL PHARMACOL GRP, GLASGOW G12 8QQ, LANARK, SCOTLAND
基金
英国医学研究理事会;
关键词
myocardial preconditioning; 7-oxo-prostacyclin; cyclic nucleotide phosphodiesterases (PDE1 & PDE4); splice variants; RT-PCR;
D O I
10.1006/jmcc.1997.0544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
M.M. KOSTIC, S. ERDOGAN, G. RENA, G. BORCHERT, B. HOCH, S. BARTEL, G. SCOTLAND, E. HUSTON, M.D. HOUSLAY AND E.-G. KRAUSE. Altered Expression of PDE1 and PDE4 Cyclic Nucleotide Phosphodiesterase Isoforms in 7-oxoprostacyclin-preconditioned Rat Heart. Journal of Molecular and Cellular Cardiology (1997) 29, 3135-3146. The stable prostacyclin derivative, 7-oxo-prostacyclin, exhibits a delayed, long-lasting cardioprotective effect, which is accompanied by an increase in cyclic nucleotide phosphodiesterase (PDE) activities restricted to the Ca2+-calmodulin-dependent (PDE1) and cyclic AMP-specific phosphodiesterase (PDE4) activities, Mammalian PDEs form a large multigene family with differential expression occurring in a cell-and tissue-specific manner, The aim of this study was to identify which isoforms of PDE1 and PDE4 are present in the hearts of control and 7-oxo-prostacyclin treated rats, Using RT-PCR analysis, we were able to identify in control rat hearts transcripts for PDE1C, but not for either PDE1A or PDE1B within the three-gene PDE1 family. Within the four-gene PDE4 family we detected, by generic RT-PCR analysis, transcripts for PDE4A, PDE4B and PDE4D, but not PDE4C. Using RT-PCR primers for specific splice variants, we identified transcripts for PDE4B1, PDE4B2, PDE4B3, PDE4D1, PDE4D2 and PDE4D3 in hearts from the control animals, Immunoblotting of hearts from the control animals for PDE4 forms allowed us to identify a 98-kDa PDE4A species, 68-kDa band representing PDE4D1/2 and a 95-kDa species indicative of PDE4D3. In the hearts of treated animals, 48 h after a single 50 mu g/kg dose of 7-oxo-prostacyclin, a profound increase in transcript levels was seen for both PDE1C and PDE4B3 together with a slight elevation for PDE4B1. No change in PDE4A transcripts occurred, which was consistent with a lack of change indicated in immunoblotting analyses. In contrast, 7-oxo-prostacyclin treatment caused decrease in transcript levels for PDE4D, which was confirmed by immunoblotting and shown to be due to a reduction in the levels of PDE4D3 and also in PDE4D1/D2. Thus, treatment of animals with 7-oxoprostacyclin initiated profound isoform-specific changes in PDE expression in the myocardium which, presumably, underpin the increased PDE activity. (C) 1997 Academic Press Limited.
引用
收藏
页码:3135 / 3146
页数:12
相关论文
共 54 条
[31]   IDENTIFICATION, CHARACTERIZATION AND REGIONAL DISTRIBUTION IN BRAIN OF RPDE-6 (RNPDE4A5), A NOVEL SPLICE VARIANT OF THE PDE4A CYCLIC-AMP PHOSPHODIESTERASE FAMILY [J].
MCPHEE, I ;
POOLEY, L ;
LOBBAN, M ;
BOLGER, G ;
HOUSLAY, MD .
BIOCHEMICAL JOURNAL, 1995, 310 :965-974
[32]  
MONACO L, 1994, J BIOL CHEM, V269, P347
[33]   Identification of cyclic AMP-phosphodiesterase variants from the PDE4D gene expressed in human peripheral mononuclear cells [J].
Nemoz, G ;
Zhang, RB ;
Sette, C ;
Conti, M .
FEBS LETTERS, 1996, 384 (01) :97-102
[34]   ACTIVATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES IN FRTL-5 THYROID-CELLS EXPRESSING A CONSTITUTIVELY ACTIVE GS-ALPHA [J].
NEMOZ, G ;
SETTE, C ;
HESS, M ;
MUCA, C ;
VALLAR, L ;
CONTI, M .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (10) :1279-1287
[35]   Cytochemical distribution of cyclic AMP-dependent 3',5'-nucleotide phosphodiesterase in the rat myocardium [J].
Okruhlicova, L ;
Tribulova, N ;
Eckly, A ;
Lugnier, C ;
Slezak, J .
HISTOCHEMICAL JOURNAL, 1996, 28 (03) :165-172
[36]   POSSIBILITIES FOR THE PHARMACOLOGICAL EXPLOITATION OF ISCHEMIC PRECONDITIONING [J].
PARRATT, JR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (04) :991-1000
[37]  
PICO M, 1995, J CARDIOVASC PHARM, V26, P742
[38]   ISOZYME-SELECTIVE INHIBITION OF CGMP-STIMULATED CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES BY ERYTHRO-9-(2-HYDROXY-3-NONYL) ADENINE [J].
PODZUWEIT, T ;
NENNSTIEL, P ;
MULLER, A .
CELLULAR SIGNALLING, 1995, 7 (07) :733-738
[39]   THE IDENTIFICATION OF A NEW CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY IN HUMAN AND GUINEA-PIG CARDIAC VENTRICLE - IMPLICATIONS FOR THE MECHANISM OF ACTION OF SELECTIVE PHOSPHODIESTERASE INHIBITORS [J].
REEVES, ML ;
LEIGH, BK ;
ENGLAND, PJ .
BIOCHEMICAL JOURNAL, 1987, 241 (02) :535-541
[40]  
SCHWABE U, 1976, MOL PHARMACOL, V12, P900